University Medical Center

Hamburg D-20246

1 studies enrolling now · 4 studies all time

What they study most

HER2-Positive Primary Breast Cancer, Hepatitis B, Hepatitis B, Chronic, Paralysis, Unilateral, Vocal Cord, Residual Invasive Breast Cancer

Studies at this site

• APrevent-VOIS-Implant-002 - a Two-Part, Open-Label, Non-Randomized Multicenter Study — Recruiting now
• A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05) — Running, not enrolling
• A Study to Assess Intrahepatic and Peripheral Changes of Immunologic and Virologic Markers in Chronic Hepatitis B Virus Infection — Completed
• A Study of Different Combination Regimens Including JNJ-73763989 and/or JNJ-56136379 for the Treatment of Chronic Hepatitis B Virus Infection — Completed